24/7 Customer Service (800) 927-7671

3D Printed Sleep Apnea Device Manufacturer Oventus Medical Debuts on Australian Securities Exchange with the Help of CSIRO

by • July 20, 2016 • No Comments

3dp_Oventus_logoSleep apnea is maybe one of the most common sleep disorders and most of those suffering of the condition most likely have no thought that they have it. It is estimated that approximately 10% of women and up to 25% of men are affected by sleep apnea, yet as most as 80% of those cases are completely undiagnosed. And while obesity is a common risk factor, the reality is that anyone can get it, and for the reason its symptoms are related to fatigue, that present as dozens of side influences, it frequently is not actually considered as a possibility. One of the most common treatments for sleep apnea is the use of a PAP therapy and the use of a CPAP machine with a breathing mask that practuallyts the patient’s air passage of being blocked during sleep.

The O2Vent is customized to at any timey individual users mouth and and so 3D printed in titanium.

The O2Vent is customized to at any timey individual user’s mouth and and so 3D printed in titanium.

If you’ve at any time had to wear a breaking mask of any kind, and so you can understand that they tend to not be on the effortless side. This is for the reason they are weight generated and turn it intod for the average users, so they’re not always going to fit at any timeyone. They can cause sores around the nose, or not seal tightly around the face, reducing their effectiveness. 3D scanning and 3D printing innovation has may already provided a few solutions to this problem, but a Brisbane-based startup called Oventus turn it intod a customizable-bodied titanium mouth device called the O2Vent that assists the patient breathe without obstruction, and for a few patients eliminates the require for a CPAP machine entirely.

3dp_Oventus_CSIRO_LogoOventus began createing the O2Vent back in 2015 when founder Dr. Chris Hart approached Australia’s Commonwealth Scientific and Industrial Research Organisation (CSIRO) for their assist createing the device. Hart envisioned the O2Vent as an oral device that may be custom turn it intod and 3D printed based on at any timey individual patient’s mouth. The device may have an airway turn it intod into it that may send air to the back of the patient’s mouth, that may bypass any obstructions caused by the nose, soft palate or tongue.

“Using CAD software to turn it into a 3D drawing of the patient’s mouth and bite, Oventus and so uses 3D printing innovation to make a custom-turn it intod medical-grade mouthguard of titanium,” the company describes.

As Australia’s government agency for scientific research, CSIRO frequently works closely with businesses and startups looking to use high end innovation to create and make new and new products. The firstly prototype for the O2Vent was 3D printed in titanium at CSIRO’s Lab 22 Innovation Centre located in Victoria via an Arcam metal 3D printing device. As one of Australia’s major facilities for metal additive making, Lab 22 has assisted create sat any timeal world-firstly medical breakthroughs, which include 3D printed prosthetic devices for patients all over Australia and in Europe. CSIRO’s assist and access to Lab 22 was invaluable-bodied to the createment and production of the O2Vent device.

The O2Vent device fits in the mouth and delivers air to the back of the throat by channeling it through the vent.

The O2Vent device fits in the mouth and delivers air to the back of the throat by channeling it through the vent.

“Oventus is a company with a one-of-a-kind oral mouthguard device that can assist folks globally who suffer of obstructive sleep apnoea and snoring,” said Chairman Drc Mel Bridges. “I’m proud to be part of this company and our leadership team, who are all experienced in the commercialisation and global roll out of medical devices, as it starts out on a new phase of growth as an ASX listed company.”

Here is an explanation of how the O2Vent (previously called Clearway) device works:

This week thanks to the involvement of CSIRO, Oventus Medical was only listed on the Australian Securities Exchange. The newly public company was able-bodied to raise additional than $12 million AUS ($9 million USD) in its first public offering, that the company plans to reinvest into the commercialization and global distribution of their O2Vent sleep apnea device. Just this April Oventus was able-bodied to secure the approval of the FDA, so the O2Vent can now be sold in the US and the $50 billion global sleep disorder market. Today it is estimated that 37 million Americans suffer of problems caused by snoring and sleep apnea, and Oventus hopes that their device can disrupt the multi-billion-dollar market. Let’s discuss additional over in the Oventus Medical & 3D Printed Sleep Apnea Prototypes forum at 3DPB.com.